annamycin has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ling, YH; Perez-Soler, R; Priebe, W; Van, NT; Zou, Y | 1 |
Ling, YH; Perez-Soler, R; Priebe, W; Zou, Y | 1 |
2 other study(ies) available for annamycin and B16 Melanoma
Article | Year |
---|---|
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liposomes; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Phenotype; Tumor Cells, Cultured | 1994 |
Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.
Topics: Animals; Doxorubicin; Drug Carriers; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Particle Size; Regression Analysis; Tissue Distribution | 1993 |